Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biohaven Ltd. Director's Dealing 2026

Mar 4, 2026

31890_dirs_2026-03-03_a95361e9-75ae-4d8f-ae91-8357c2cf2bca.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biohaven Ltd. (BHVN)
CIK: 0001935979
Period of Report: 2026-02-27

Reporting Person: Coric Vlad (Director, Chief Executive Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-27 Stock Options (Right to buy) $11.52 A 550000 Acquired 2036-02-27 Common Shares (550000) Direct

Footnotes

F1: The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date.